Additionally, PARP1 variably modulates autophagy via the MRPL21-PARP1 axis to promote chemoresistance in head and neck squamous cell carcinoma [124], while being activated by UHRF2 to promote autophagy and malignancy in hepatocellular carcinoma [125]. The gene discussed is PARP1; the disease is hepatocellular carcinoma.